DePuy Synthes Aims to Improve Operations with Ortho Restructure Chart of the Month The Numbers Our chart of the month tracks DePuy Synthes’ sales by business unit from 2016 through our 2023 projection. Nov 20, 2023
Anika Brings Innovative Design Philosophy to Reverse Shoulder Market Executive Insights Industry Voices We spoke with Anika President and CEO Cheryl Blanchard, Ph.D. about the RevoMotion launch, ASCs, and robotics in the shoulder market. Nov 20, 2023
OrthoPediatrics Sees Opportunity to Claim Dominant Share Position Company Revenue The Numbers The company grew in the mid-teens in 3Q23 and sees competitors putting less focus on treating pediatric trauma and deformity. Nov 15, 2023
Vericel Extends Growth Streak, Preps for Arthroscopic MACI Company Revenue The Numbers The company notched its fifth consecutive quarter with more than 20% growth and is on track for arthroscopic MACI delivery in 1H24. Nov 15, 2023
Orthofix Fundamentals and Merger Thesis Remain Intact Company Revenue The Numbers The company grew 61% as-reported in the third quarter of 2023, or 1.2% on a pro forma basis including prior year SeaSpine sales. Nov 14, 2023
Paragon 28 Delivers Strong Performance Despite Supply Pinch Company Revenue The Numbers The company grew in the mid-teens during the third quarter of 2022, driven by sales force and active surgeon base growth. Nov 14, 2023
Treace Medical Surprised by 3Q Seasonality Company Revenue The Numbers The company grew more than 23% in 3Q23 but ultimately reduced its guidance because of higher-than-expected seasonality during the summer. Nov 14, 2023
Bioventus OA Pain Business Returns to Growth Ahead of Schedule Company Revenue The Numbers The company grew in the low single digits in the third quarter of 2023 as its OA pain sales volume offset price declines. Nov 14, 2023
Enovis on Cusp of $1 Billion Recon Business Company Revenue The Numbers The company's orthopedic sales grew in the mid-teens during the third quarter of 2023, as it continues to win market share from peers. Nov 09, 2023
Zimmer Biomet Confident in Sustained Growth Momentum Company Revenue The Numbers The company grew in the mid-single-digits in the third quarter of 2023, driven by knee replacement and its SET product category. Nov 08, 2023